Tevogen Bio Holdings (TVGN) Retained Earnings (2021 - 2026)

Tevogen Bio Holdings has reported Retained Earnings for 6 years, with the latest figure at -$145.1 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 17.26% year-over-year to -$145.1 million; the trailing twelve-month figure through Mar 2026 stood at -$145.1 million (down 17.26% YoY), and the FY2025 full-year result was -$139.7 million, down 23.17% from the prior year.
• Retained Earnings for Q1 2026 stood at -$145.1 million, down from -$139.7 million in the prior quarter.
• The five-year high for Retained Earnings was -$14.0 million in Q2 2022, with the low at -$145.1 million in Q1 2026.
• Historically, Retained Earnings has averaged -$75.4 million across 5 years, with a median of -$98.1 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings declined 3.9% — and 2023, when it plunged 574.06%.
• Tevogen Bio Holdings' Retained Earnings stood at -$14.8 million in 2022, then sank by 574.06% to -$99.7 million in 2023, then slipped by 13.77% to -$113.4 million in 2024, then declined by 23.17% to -$139.7 million in 2025, then dropped by 3.9% to -$145.1 million in 2026.
• The last three Retained Earnings figures came in at -$145.1 million (Q1 2026), -$139.7 million (Q4 2025), and -$135.0 million (Q3 2025), per Business Quant data.